The advantages of aminolevulinic acid photodynamic therapy in dermatology.
Photodynamic therapy (PDT) is being increasingly employed in the detection and treatment of malignant and non-malignant disease. This local technique uses a photosensitizing drug activated by light to generate cell death via the production of reactive oxygen species. This review describes the fundamental processes behind PDT, focussing on the use of 5-aminolevulinic acid (ALA). ALA itself is not a photosensitizing drug, but administration of exogenous ALA induces the build-up of the natural endogenous photosensitizer protoporphyrin IX (PpIX). This form of PDT has proved promising for the treatment of a number of dermatological indications. An overview of these current and potential applications of ALA-based PDT is presented, with emphasis on the advantages of the technique that make it especially suitable for skin conditions and the problem areas on which future research should be focussed.
Taylor
E L
EL
Centre for Photobiology and Photodynamic Therapy, School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK.
Brown
S B
SB
D000622:Aminolevulinic Acid / Q000494:pharmacology*; D006801:Humans; D010778:Photochemotherapy / Q000379:methods*; D017319:Photosensitizing Agents / Q000494:pharmacology*; D012871:Skin Diseases / Q000188:drug therapy*
D017319:Photosensitizing Agents; D000622:Aminolevulinic Acid